Business & Economy

Pfizer’s Legal Battle Exposes Risky Globalist Tactics in Pharma Takeovers

By Patriot News Investigative Desk | November 1, 2025

Pfizer takes a stand against Novo Nordisk’s aggressive $9 billion bid for Metsera, highlighting the risks of market dominance and regulatory uncertainty that threaten fair competition and American innovation.

This is Exclusive Content for Subscribers

Join our community of patriots to read the full story and get access to all our exclusive analysis.

View Subscription Plans